CACI's Q1 Numbers Are Out: What the Data Said Going In

CACI International reports its first-quarter fiscal 2027 results on October 22, and the positioning data tell a story that has shifted materially since the two earnings previews published earlier this month.

The options market spent the past two weeks registering unusually strong call demand. The put/call ratio ended Tuesday at 0.2475, fractionally above its 52-week low of 0.2435 hit just two sessions earlier. That compares with a 20-day average of 0.26 and sits 1.7 standard deviations below it, a level of call skew that has been consistent for most of October after a step-down from the 0.39 range that prevailed through August and September. Short interest, meanwhile, has come down from its intra-month peak: after building to roughly 1.19 million shares in mid-October, it trimmed back to 1.06 million by October 20, or about 4.8% of the free float, down 8% over the week. The borrow market is offering no signal either way. Availability is exceptionally loose at 1,522% of shares short, with a cost to borrow of 0.42%, and utilization has rarely pushed above 8% over the past month. Shorts are present but not pressed. Collectively, the lending and options data describe investors who leaned into the print long rather than defensively hedged.

The analyst community moved in two directions at once in the days immediately before the release. Cantor Fitzgerald raised its target to $785 from $675 on October 21, maintaining its Overweight rating. Macquarie initiated coverage at Outperform with an $780 target on October 16. Citigroup, in contrast, lifted its own target more modestly to $689 while holding at Neutral on October 7. BNP Paribas sits at the other end: the firm downgraded to Underperform on October 6 and cut its target to $540. The consensus mean target of $739.93 implies roughly 22% upside to the October 20 close of $607.75, though that average masks the wide range between the outlier bear at $540 and bulls clustered in the high $700s to $804. Valuation is not demanding by historical standards: the PE is near 16.5x and EV/EBITDA is at 12.7x, both compressing over the past 30 days. Forward earnings momentum ranks in the 88th percentile on a 90-day basis, a factor score that has been rising and which the bull case points to as the core reason for confidence.

The split between those two camps maps cleanly onto the stock's own recent data. The bull case rests on backlog coverage, free cash flow generation of $281 million year-to-date, and fiscal 2026 revenue guidance of $9.3 to $9.5 billion, representing 8% to 10% growth year on year. The bear case centres on the FQ2 revenue miss, a book-to-bill ratio of just 0.6x, and a declining funded backlog at $4.4 billion, which represents thinner coverage than the company carried in prior cycles. Federal budget uncertainty and competitive pricing pressure are the two variables that neither side disputes.

What makes CACI an interesting study for the October 22 print is how little the closest peers have moved in lockstep. LDOS gained 6.7% over the past week and BAH rose 3.7%, while CACI ended the same period down 0.3%. That gap has widened a pattern noted in earlier notes, where CACI's heavier exposure to government contract cycles has held it back as sentiment improved broadly across defense IT. The insider register adds little signal here: the only activity recorded in October consists of option exercises and tax withholding transactions from the SVP and several directors, none of them open-market purchases that would indicate personal conviction at the current price.

The key question around the October 22 release is whether the book-to-bill trajectory from FQ2 has stabilised, and whether management updates the $9.3 to $9.5 billion revenue range, up or down.